Molecular similarity considerations in the licensing of orphan drugs
Drug Discovery Today(2017)
Abstract
•Authorisation and evaluation of orphan drugs.•Similarity in the in the context of the orphan drug legislation.•2D fingerprints used to evaluate similarity of orphan medicines.•Human assessment versus computer assessment.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined